Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 21-30 of 147 for

Edit search filters
  1. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease

    Rochester, MN

  2. AMG 181 Phase 2 Study in Subjects with Moderate to Severe Ulcerative Colitis

    Rochester, MN

  3. Stem Cell Coated Fistula Plug in Patients With Crohn's RVF

    Rochester, MN

  4. Safety and Efficacy of GS-5745 in Participants With Moderately to Severely Active Crohn's Disease

    Scottsdale/Phoenix, AZ

  5. A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Patients Who Are Naive to TNF Inhibitors

    Rochester, MN

  6. A Study of Oral Ozanimod as Maintenance Therapy for Moderately-to-Severely Active Crohn's Disease

    La Crosse, WI

  7. A Study of Eluxadoline in Participants with Irritable Bowel Syndrome with Diarrhea (IBS-D) Who Have Evidence of Bile Acid Malabsorption (BAM)

    Rochester, MN

  8. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment

    Rochester, MN, Rochester, MN

  9. A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis

    Rochester, MN

  10. TD-1473 for Active Ulcerative Colitis (UC)

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer